Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Amneal Pharmaceuticals with status Current. The shortage was first posted on Jul 14, 2023.
Shortage details
- Status
- Current
- Company
- Amneal Pharmaceuticals
- Package NDC
- 65162-024-09
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)
- Initial Posting
- Jul 14, 2023